Acute LeukemiaPACE-ALNCT01404520
Patient Activation, Counseling and Exercise - Acute Leukemia (PACE-AL)
A study testing Exercise based multimodal intervention in people with Acute Leukemia, run by Universitetshospitalernes Center for Sygepleje at 2 sites in Denmark.
Trial summary
The purpose of this study is to test a new preventive and restorative intervention for patients with acute leukaemia undergoing consolidation chemotherapy, to measure and delineate the patients' treatment related symptom burden and to explore the effect of the intervention on length of hospital stay, duration of sick… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Acute Leukemia
- What is being tested?
- Exercise based multimodal intervention
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 70 participants
- Where
- 2 sitesDenmark
- Study dates
- Jun 2011to May 2015
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Patients that are able to speak Danish > 18 years and newly diagnosed with acute leukæmia (MDS, AML, CMML, APL or ALL)
- Normal EKG, blood pressure and pulse
- Signed informed written consent
Who cannot join
- Medical reason that contraindicates physical activity
- Patients diagnosed with a symptomatic cardial disease
- Documented bone metastasis
- Cognitively or emotionally unstable
- Unable to read or write in Danish
- Patients unable to carry out baseline tests
Trial locations and contacts
2 sites in 1 country.
Denmark2 sites
Copenhagen University Hospital Rigshospital
Copenhagen, DK 2100
Herlev Hospital
Herlev, DK 2730
About this study
Official title: Patient Activation, Counseling and Exercise - Acute Leukemia (PACE-AL) Health Promoting Rehabilitation. A Multimodal Exercise-based Intervention in Patients With Acute Leukaemia Undergoing Re-induction or Consolidation Chemotherapy
The purpose of this study is to test a new preventive and restorative intervention for patients with acute leukaemia undergoing consolidation chemotherapy, to measure and delineate the patients' treatment related symptom burden and to explore the effect of the intervention on length of hospital stay, duration of sick leave and return to work status. Further, to examine the relationship of the symptom profile with clinical indicators, physiological response, physical performance and survival.
- Conditions
- Acute Leukemia
- Being tested
- Exercise based multimodal intervention
- Keywords
- #14 Cancer Related fatigue, #13 Quality of Life, #12 "Psychosocial Intervention"[ti/ab], #11 Rehabilitation[tw], #10 "Physical Fitness"[tw], #9 "Physical Activity"[tw], #8 "Exercise Therapy"[tw], #7 Exercise[tw], #6 Hematologic[tw], #5 Hematological[tw], #4 Leukemia, Myeloid, Acute[mh], #3 "Acute Myeloid Leukemia"[tw], #2 "Acute Lymphoblastic Leukemia"[tw], #1 "Acute Leukemia"[tw]
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Exercise based multimodal interventionOther
The intervention is initiated early, during treatment (consolidation) in the intra-hospital setting and continues for two successive treatment series (12 weeks). The intervention is a three hour/wk supervised in-hospital programme of aerobic (stationary cycle) and functional muscle training, progressive relaxation training, nutrition supplement (protein and carbohydrate) immediately after training and health-promoting consultation combined with an unsupervised in-home walking and progressive relaxation programme.
| Study group | Role | What they receive |
|---|---|---|
| Exercise based multimodal intervention | Experimental | The intervention is initiated early, during treatment (consolidation) in the intra-hospital setting and continues for two successive treatment series (12 weeks). The intervention is a three hour/wk supervised in-hospital programme of aerobic (stationary cycle) and functional muscle training, progressive relaxation training, nutrition supplement (protein and carbohydrate) immediately after training and health-promoting consultation combined with an unsupervised in-home walking and progressive relaxation programme Receives: Other: Exercise based multimodal intervention |
| Control Group | No intervention | Control group receives usual care |
What is being measured
The primary outcome is the main question the study is designed to answer.
Six Minute Walk Distance 6MWD
Change in distance in meter
Measured: Change from baseline in 6MWD at 12 weeks
Secondary outcomes (8)
Estimated VO2 max Aastrand test
Change in l/m
Measured: Change from baseline in VO2 Aastrand test at 12 weeks
Timed chair stand
Change in number of repetitions
Measured: Change from baseline in timed chair stand at 12 weeks
Timed biceps curl
Change in number of repetitions
Measured: Change from baseline in timed bicep curl at 12 weeks
EORTC QLQ-C30
Change in scores for quality of life
Measured: Change from baseline in EORTC QLQ-C30 at 12 weeks
FACT-An
Change in scores for quality of life/function
Measured: Change from baseline in FACT-An at 12 weeks
HADS
Change in scores for emotional wellbeing
Measured: Change from baseline in HADS at 12 weeks
SF36
Change in scores for general health
Measured: Change from baseline in SF36 at 12 weeks
MDASI
Change in scores for symptom burden
Measured: Change from baseline over time (1,2,3,4,5,6,7,8,9,10,11,12 weeks)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Jul 2011 (estimated)
- Study startJun 2011
- Primary completionMay 2014
- Study completionMay 2015
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Acute LeukemiaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 70 participants (actual)
Sponsor and investigators
- Lead sponsor
- Universitetshospitalernes Center for Sygepleje
- Sponsor type
- University, hospital or other
- Collaborators
- University of Copenhagen, Novo Nordisk A/S, Danish Cancer Society, Lundbeck Foundation
- Responsible party
- Principal investigator, Mary Jarden, Universitetshospitalernes Center for Sygepleje
- Investigators
- Mary Jarden, Ph.D., Principal investigator, UCSF and CIRE
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01404520
- Sponsor's protocol ID
- H-4-2010-046
- Acronym
- PACE-AL
- Status last verified
- Nov 2015
- First submitted
- 10 May 2011
- Last updated
- 2 Dec 2015
- Results posted
- No
- Data monitoring committee
- Yes
Publications
Jarden M, Moller T, Christensen KB, Kjeldsen L, Birgens HS, Adamsen L. Multimodal intervention integrated into the clinical management of acute leukemia improves physical function and quality of life during consolidation chemotherapy: a randomized trial 'PACE-AL'. Haematologica. 2016 Jul;101(7):e316-9. doi: 10.3324/haematol.2015.140152. Epub 2016 Apr 1. No abstract available.
PubMed 27036163Jarden M, Moller T, Kjeldsen L, Birgens H, Christensen JF, Bang Christensen K, Diderichsen F, Hendriksen C, Adamsen L. Patient Activation through Counseling and Exercise--Acute Leukemia (PACE-AL)--a randomized controlled trial. BMC Cancer. 2013 Oct 2;13:446. doi: 10.1186/1471-2407-13-446.
PubMed 24083543
Study at a glance
From the registry record, last updated by the sponsor on 2 Dec 2015. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Patient Activation, Counseling and Exercise - Acute Leukemia (PACE-AL) Health Promoting Rehabilitation. A Multimodal Exercise-based Intervention in Patients With Acute Leukaemia Undergoing Re-induction or Consolidation Chemotherapy
- ClinicalTrials.gov ID
- NCT01404520
- Acronym / sponsor ID
- PACE-AL / H-4-2010-046
- Conditions
- Acute Leukemia
- Keywords
- #14 Cancer Related fatigue, #13 Quality of Life, #12 "Psychosocial Intervention"[ti/ab], #11 Rehabilitation[tw], #10 "Physical Fitness"[tw], #9 "Physical Activity"[tw], #8 "Exercise Therapy"[tw], #7 Exercise[tw]
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 70 participants (actual)
- Lead sponsor
- Universitetshospitalernes Center for SygeplejeUniversity, hospital or other
- Collaborators
- University of Copenhagen, Novo Nordisk A/S, Danish Cancer Society, Lundbeck Foundation
- Study start
- Jun 2011
- Primary completion
- May 2014 (actual)
- Study completion
- May 2015 (actual)
- First posted
- 28 Jul 2011 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to test a new preventive and restorative intervention for patients with acute leukaemia undergoing consolidation chemotherapy, to measure and delineate the patients' treatment related symptom burden and to explore the effect of the intervention on length of hospital stay, duration of sick leave and return to work status. Further, to examine the relationship of the symptom profile with clinical indicators, physiological response, physical performance and survival.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Exercise based multimodal intervention | Experimental | Other: Exercise based multimodal interventionThe intervention is initiated early, during treatment (consolidation) in the intra-hospital setting and continues for two successive treatment series (12 weeks). The intervention is a three hour/wk supervised in-hospital programme of aerobic (stationary cycle) and functional muscle training, progressive relaxation training, nutrition supplement (protein and carbohydrate) immediately after training and health-promoting consultation combined with an unsupervised in-home walking and progressive relaxation programme |
| Control Group | No intervention | –Control group receives usual care |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Patients that are able to speak Danish > 18 years and newly diagnosed with acute leukæmia (MDS, AML, CMML, APL or ALL)
- Normal EKG, blood pressure and pulse
- Signed informed written consent
Key exclusion criteria (6 listed)
- Medical reason that contraindicates physical activity
- Patients diagnosed with a symptomatic cardial disease
- Documented bone metastasis
- Cognitively or emotionally unstable
- Unable to read or write in Danish
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Exercise based multimodal interventionThe intervention is initiated early, during treatment (consolidation) in the intra-hospital setting and continues for two successive treatment series (12 weeks). The intervention is a three hour/wk supervised in-hospital programme of aerobic (stationary cycle) and functional muscle training, progressive relaxation training, nutrition supplement (protein and carbohydrate) immediately after training and health-promoting consultation combined with an unsupervised in-home walking and progressive relaxation programme. | Other | Exercise based multimodal intervention |
Primary outcome
Six Minute Walk Distance 6MWD
Time frame: Change from baseline in 6MWD at 12 weeks
Change in distance in meter
8 secondary outcomes
Estimated VO2 max Aastrand test
Time frame: Change from baseline in VO2 Aastrand test at 12 weeks
Timed chair stand
Time frame: Change from baseline in timed chair stand at 12 weeks
Timed biceps curl
Time frame: Change from baseline in timed bicep curl at 12 weeks
EORTC QLQ-C30
Time frame: Change from baseline in EORTC QLQ-C30 at 12 weeks
FACT-An
Time frame: Change from baseline in FACT-An at 12 weeks
HADS
Time frame: Change from baseline in HADS at 12 weeks
SF36
Time frame: Change from baseline in SF36 at 12 weeks
MDASI
Time frame: Change from baseline over time (1,2,3,4,5,6,7,8,9,10,11,12 weeks)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Dec 2015.
- Derived from this study: PubMed 27036163Jarden M, Moller T, Christensen KB, Kjeldsen L, Birgens HS, Adamsen L. Multimodal intervention integrated into the clinical management of acute leukemia improves physical function and quality of life during consolidation chemotherapy: a randomized trial 'PACE-AL'. Haematologica. 2016 Jul;101(7):e316-9. doi: 10.3324/haematol.2015.140152. Epub 2016 Apr 1. No abstract available.
- Derived from this study: PubMed 24083543Jarden M, Moller T, Kjeldsen L, Birgens H, Christensen JF, Bang Christensen K, Diderichsen F, Hendriksen C, Adamsen L. Patient Activation through Counseling and Exercise--Acute Leukemia (PACE-AL)--a randomized controlled trial. BMC Cancer. 2013 Oct 2;13:446. doi: 10.1186/1471-2407-13-446.
Related trials for Acute Leukemia
Recruiting
A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
B-All, Acute Lymphoblastic Leukemia
RecruitingPhase 3
A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia
B-cell Acute Lymphoblastic Leukemia
Not yet recruiting
Busulfan-Based Versus TBI-Based Conditioning for Adult ALL-CR2 Allo-HSCT
Acute Lymphoblastic Leukemia, Hematopoietic Stem Cell Transplantation
Not yet recruitingPhase 1
BLinatumomab and iNKT in Relapsed B-Cell ALL
B-Cell ALL, ALL (Acute B-Lymphoblastic Leukemia)
Not yet recruitingPhase 2
Revumenib, Azacitidine, and VENetoclax in Newly Diagnosed KMT2A-Rearranged AML
Leukemia Acute Myeloid
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Mary Jarden, Ph.D. principal investigator
UCSF and CIRE
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Exercise based multimodal intervention in people with Acute Leukemia, run by Universitetshospitalernes Center for Sygepleje at 2 sites in Denmark.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 2 Dec 2015. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Six Minute Walk Distance 6MWD (time frame: Change from baseline in 6MWD at 12 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01404520, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Dec 2015.